| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/24/1996 | EP0707579A1 Piperidinyl substituted methanoanthracenes as d1/d2-antagonists and 5ht2-serotanin-antagonists |
| 04/24/1996 | EP0707577A1 Heme binding compounds and use thereof |
| 04/24/1996 | EP0707574A1 Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives |
| 04/24/1996 | EP0707573A1 Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents |
| 04/24/1996 | EP0707571A1 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands |
| 04/24/1996 | EP0707570A1 Isoquinoline derivatives as therapeutic agents |
| 04/24/1996 | EP0707568A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 04/24/1996 | EP0707566A1 Novel structural analogues of vitamin d |
| 04/24/1996 | EP0707564A1 Difluoro statone analogs |
| 04/24/1996 | EP0707496A1 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN inhA GENE |
| 04/24/1996 | EP0707495A1 Compositions for treating hypoxia-associated ocular complications |
| 04/24/1996 | EP0707492A1 H 2? antagonist-gastrointestinal motility agent combinations |
| 04/24/1996 | EP0707487A1 Methods and pharmaceutical compositions useful for treating neurological disorders |
| 04/24/1996 | EP0707484A1 H 2? antagonist-alginate-antacid combinations |
| 04/24/1996 | EP0707483A1 Methods for inhibiting skin ulceration by use of cyanoacrylate adhesives |
| 04/24/1996 | EP0707482A1 Erythromycin derivatives |
| 04/24/1996 | EP0707481A1 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 04/24/1996 | EP0707480A1 Antineoplastic compositions and methods of use |
| 04/24/1996 | EP0707479A1 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin |
| 04/24/1996 | EP0707478A1 Improved nicotine lozenge and therapeutic method for smoking cessation |
| 04/24/1996 | EP0707477A1 Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases |
| 04/24/1996 | EP0707476A1 Compounds for the photodecontamination of pathogens in blood |
| 04/24/1996 | EP0707475A1 Extended release, film-coated tablet of astemizole and pseudoephedrine |
| 04/24/1996 | EP0707471A1 Novel therapeutic drug delivery systems |
| 04/24/1996 | EP0707465A1 Monolithic matrix transdermal delivery system |
| 04/24/1996 | EP0707446A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
| 04/24/1996 | EP0689545A4 Macrocyclic amide and urea immunomodulators |
| 04/24/1996 | EP0662819B1 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof |
| 04/24/1996 | EP0625194B1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
| 04/24/1996 | EP0609371B1 Thienopyrazine-2,3-diones useful for treating cns disorders, and their preparation. |
| 04/24/1996 | EP0602097B1 Tricyclic thiazol and oxazol derivates with antiviral action |
| 04/24/1996 | EP0575370B1 Process for the purification of lofepramine by crystallisation |
| 04/24/1996 | EP0573562B1 Dihydroquinoline NMDA antagonists |
| 04/24/1996 | EP0564658B1 2-(2,3-dicarboxycyclopropyl)glycine and method for producing the same |
| 04/24/1996 | EP0533825B1 Ether lipid-nucleoside covalent conjugates |
| 04/24/1996 | EP0450097B1 Benzoheterocyclic compounds |
| 04/24/1996 | CN1121349A Heterocyclic compounds and their preparation and use |
| 04/24/1996 | CN1121348A Indole derivatives as 5-H1-like agonists for use in migraine |
| 04/24/1996 | CN1121347A Method and apparatus for extracting taxol from source materials |
| 04/24/1996 | CN1121346A 10,11-methanodibenzosuberane derivaties used as chemosensitizing agents |
| 04/24/1996 | CN1121345A New compounds |
| 04/24/1996 | CN1121344A New compounds |
| 04/24/1996 | CN1121312A Chlamydia vaccine and process |
| 04/24/1996 | CN1121311A Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 04/24/1996 | CN1121078A Safe and water-soluble polysaccharide material and its preparation method and uses |
| 04/24/1996 | CN1121076A 1,4-diazepine derivative and its pharmaceutical use |
| 04/24/1996 | CN1121075A Alkaloids from mappia foetida, the use thereof and formulations containing them |
| 04/24/1996 | CN1121074A Novel N-pyridyl carboxamides and derivatives, processes for their preparation and the pharmaceutical compositions which contain them |
| 04/24/1996 | CN1121072A Acetamides |
| 04/24/1996 | CN1121070A Process for preparing pyrimidinetrione derivatives |
| 04/24/1996 | CN1120949A Addiction-eliminating and body resistance-strengthening capsule |
| 04/24/1996 | CN1120937A Processing method of polypropylene for high molecular synthetic material double-fold eyelid operation |
| 04/24/1996 | CN1120936A Process for the production of a pharmaceutical composition comprising an ATP anologue |
| 04/24/1996 | CN1120934A Agent for treatment of glaucoma and agent for reducing eye pressure |
| 04/24/1996 | CN1031668C Multi-purpose nozzle of gas stove and range |
| 04/24/1996 | CN1031664C Lining cable for pipe lining |
| 04/24/1996 | CN1031648C Carrot beer and its preparing method |
| 04/24/1996 | CN1031643C Novel glycoside compounds and production thereof |
| 04/24/1996 | CN1031642C Process for preparing of 6-substituted purinyl piperazine derivatives |
| 04/24/1996 | CN1031641C Process for preparing 8-substituted xanthine |
| 04/24/1996 | CN1031639C Method for preparing crystal of phenoxy alkylamine compound using as anti-hypertension drug |
| 04/24/1996 | CN1031619C Oxazolidone derivative |
| 04/24/1996 | CN1031618C Process for preparing mixture with N-aminoalkyl-aza-spiro alkane derivatives as its active composition |
| 04/23/1996 | USRE35218 For gastrointestinal disorders |
| 04/23/1996 | US5510504 Esterifying amino-protected bis/aminomethyl/phosphinic acid, removing protective groups, reacting with imine or ketone, reacting with base and alkylating agent, treating with acid |
| 04/23/1996 | US5510498 Benzothiophene compounds, intermediates, compositions, and methods |
| 04/23/1996 | US5510496 Substituted pyrazolyl benzenesulfonamides |
| 04/23/1996 | US5510488 Chemical intermeidates |
| 04/23/1996 | US5510487 Retroviral protease inhibitors |
| 04/23/1996 | US5510485 Pregnanes or androstanes; antiandrogens, hormone inhibitors |
| 04/23/1996 | US5510480 Certain azacycloalkyl imidazopyrimidines: a new class of GABA brain receptor ligands |
| 04/23/1996 | US5510469 2-acyloxy-4-morpholinyl anthracyclines |
| 04/23/1996 | US5510464 Administration of low dose hemoglobin to increase perfusion |
| 04/23/1996 | US5510391 Method of treating blood vessel disorders of the skin using vitamin K |
| 04/23/1996 | US5510390 Administering polyalkylene-amines or salts thereof |
| 04/23/1996 | US5510389 Containing acetaminophen formed by adding an electrophilic beckman rearrangement catalyst to 4-hydroxyacetophenone oxime, a polyoxyethylene glycol, polyvinylpyrrolidone, and propylene glycol; solubility, stability |
| 04/23/1996 | US5510388 Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 04/23/1996 | US5510387 Antimicrobial interferon-inducing medicament |
| 04/23/1996 | US5510386 Aminosulfonylphenyl compounds for treating urinary incontinence |
| 04/23/1996 | US5510385 Analgesics, antiinflammatory agents |
| 04/23/1996 | US5510384 Topical application as wound healing agent |
| 04/23/1996 | US5510383 Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
| 04/23/1996 | US5510382 Administering prostaglandin e derivatives |
| 04/23/1996 | US5510381 Therapeutic use of gabapentin, its derivatives |
| 04/23/1996 | US5510378 Retroviral protease inhibitors |
| 04/23/1996 | US5510376 Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents |
| 04/23/1996 | US5510372 For treating or preventing insect or worm infestations in animals |
| 04/23/1996 | US5510371 Inhibitors of farnesyl-protein transferase |
| 04/23/1996 | US5510370 Osteoporosis, osteoarthritis treatment |
| 04/23/1996 | US5510369 Pyrrolidine thrombin inhibitors |
| 04/23/1996 | US5510367 Indole derivatives |
| 04/23/1996 | US5510365 Suppression of tumor necrosis factor (tnfalpha) activity |
| 04/23/1996 | US5510362 Imidazole, triazole and tetrazole derivatives |
| 04/23/1996 | US5510361 Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents |
| 04/23/1996 | US5510360 Administering orally, side effect reduction |
| 04/23/1996 | US5510359 Heteroaromatic 5-hydroxytryptamine receptor agonists |
| 04/23/1996 | US5510358 Osteoporosis |
| 04/23/1996 | US5510357 Benzothiophene compounds as anti-estrogenic agents |
| 04/23/1996 | US5510355 Depolarizing skeletal muscle relaxants |
| 04/23/1996 | US5510353 Treating irritable bowel syndrome, gastroesophageal reflux disease, constipation, migraine headaches |